BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 24101104)

  • 1. Identification of CD90 as a marker for lung cancer stem cells in A549 and H446 cell lines.
    Yan X; Luo H; Zhou X; Zhu B; Wang Y; Bian X
    Oncol Rep; 2013 Dec; 30(6):2733-40. PubMed ID: 24101104
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Trastuzumab (herceptin) targets gastric cancer stem cells characterized by CD90 phenotype.
    Jiang J; Zhang Y; Chuai S; Wang Z; Zheng D; Xu F; Zhang Y; Li C; Liang Y; Chen Z
    Oncogene; 2012 Feb; 31(6):671-82. PubMed ID: 21743497
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enrichment and characterization of cancer stem cells from a human non-small cell lung cancer cell line.
    Zhao C; Setrerrahmane S; Xu H
    Oncol Rep; 2015 Oct; 34(4):2126-32. PubMed ID: 26239272
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A CD90(+) tumor-initiating cell population with an aggressive signature and metastatic capacity in esophageal cancer.
    Tang KH; Dai YD; Tong M; Chan YP; Kwan PS; Fu L; Qin YR; Tsao SW; Lung HL; Lung ML; Tong DK; Law S; Chan KW; Ma S; Guan XY
    Cancer Res; 2013 Apr; 73(7):2322-32. PubMed ID: 23382045
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of local and circulating cancer stem cells in human liver cancer.
    Yang ZF; Ngai P; Ho DW; Yu WC; Ng MN; Lau CK; Li ML; Tam KH; Lam CT; Poon RT; Fan ST
    Hepatology; 2008 Mar; 47(3):919-28. PubMed ID: 18275073
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Significance of CD90+ cancer stem cells in human liver cancer.
    Yang ZF; Ho DW; Ng MN; Lau CK; Yu WC; Ngai P; Chu PW; Lam CT; Poon RT; Fan ST
    Cancer Cell; 2008 Feb; 13(2):153-66. PubMed ID: 18242515
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential expression of CD90 and CD14 stem cell markers in malignant breast cancer cell lines.
    Lobba AR; Forni MF; Carreira AC; Sogayar MC
    Cytometry A; 2012 Dec; 81(12):1084-91. PubMed ID: 23090904
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CD90 a potential cancer stem cell marker and a therapeutic target.
    Shaikh MV; Kala M; Nivsarkar M
    Cancer Biomark; 2016; 16(3):301-7. PubMed ID: 27062695
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Human non-small cell lung cancer expresses putative cancer stem cell markers and exhibits the transcriptomic profile of multipotent cells.
    Zakaria N; Yusoff NM; Zakaria Z; Lim MN; Baharuddin PJ; Fakiruddin KS; Yahaya B
    BMC Cancer; 2015 Feb; 15():84. PubMed ID: 25881239
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CD90 and CD110 correlate with cancer stem cell potentials in human T-acute lymphoblastic leukemia cells.
    Yamazaki H; Nishida H; Iwata S; Dang NH; Morimoto C
    Biochem Biophys Res Commun; 2009 May; 383(2):172-7. PubMed ID: 19341705
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification and characterization of cells with cancer stem cell properties in human primary lung cancer cell lines.
    Wang P; Gao Q; Suo Z; Munthe E; Solberg S; Ma L; Wang M; Westerdaal NA; Kvalheim G; Gaudernack G
    PLoS One; 2013; 8(3):e57020. PubMed ID: 23469181
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Notch pathway promotes the cancer stem cell characteristics of CD90+ cells in hepatocellular carcinoma.
    Luo J; Wang P; Wang R; Wang J; Liu M; Xiong S; Li Y; Cheng B
    Oncotarget; 2016 Feb; 7(8):9525-37. PubMed ID: 26848615
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic value of cancer stem cells, epithelial-mesenchymal transition and circulating tumor cells in lung cancer.
    Pirozzi G; Tirino V; Camerlingo R; La Rocca A; Martucci N; Scognamiglio G; Franco R; Cantile M; Normanno N; Rocco G
    Oncol Rep; 2013 May; 29(5):1763-8. PubMed ID: 23426441
    [TBL] [Abstract][Full Text] [Related]  

  • 14. miR-27a regulates the self renewal of the H446 small cell lung cancer cell line in vitro.
    Miao Y; Li J; Qiu X; Li Y; Wang Z; Luan Y
    Oncol Rep; 2013 Jan; 29(1):161-8. PubMed ID: 23117485
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The prognostic value of combination of CD90 and OCT4 for hepatocellular carcinoma after curative resection.
    Zhao RC; Zhou J; Chen KF; Gong J; Liu J; He JY; Guan P; Li B; Qin Y
    Neoplasma; 2016; 63(2):288-98. PubMed ID: 26674131
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Overlapping genes may control reprogramming of mouse somatic cells into induced pluripotent stem cells (iPSCs) and breast cancer stem cells.
    Mosca E; Cocola C; Sabour D; Pelucchi P; Bertalot G; Palumbo O; Carella M; Götte M; Schöler HR; Reinbold R; Zucchi I; Milanesi L
    In Silico Biol; 2010; 10(5-6):207-21. PubMed ID: 22430355
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of cancer stem cells in vincristine preconditioned SGC7901 gastric cancer cell line.
    Xue Z; Yan H; Li J; Liang S; Cai X; Chen X; Wu Q; Gao L; Wu K; Nie Y; Fan D
    J Cell Biochem; 2012 Jan; 113(1):302-12. PubMed ID: 21913215
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MiR-155 targets TP53INP1 to regulate liver cancer stem cell acquisition and self-renewal.
    Liu F; Kong X; Lv L; Gao J
    FEBS Lett; 2015 Feb; 589(4):500-6. PubMed ID: 25601564
    [TBL] [Abstract][Full Text] [Related]  

  • 19. SOX2 is overexpressed in stem-like cells of human lung adenocarcinoma and augments the tumorigenicity.
    Nakatsugawa M; Takahashi A; Hirohashi Y; Torigoe T; Inoda S; Murase M; Asanuma H; Tamura Y; Morita R; Michifuri Y; Kondo T; Hasegawa T; Takahashi H; Sato N
    Lab Invest; 2011 Dec; 91(12):1796-804. PubMed ID: 21931300
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lung cancer stem cells research. Clues from ontogeny.
    Xu Y; Hu YD
    Saudi Med J; 2009 Nov; 30(11):1381-9. PubMed ID: 19882047
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.